Litcius/Paper detail

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease

Joseph Pierre Aboumsallem, Javid J. Moslehi, Rudolf A. de Boer

2020Journal of the American Heart Association173 citationsDOIOpen Access PDF

Abstract

Dr de Boer is supported by the European Research Council (CoG 818715 and SECRETE-HF); and further by the Netherlands Heart Foundation (CVON DOSIS, grant 2014-40; CVON SHE-PREDICTS-HF, grant 2017-21; CVON RED-CVD, grant 2017-11; and CVON PREDICT2, grant 2018-30); the Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research (NWO VIDI, grant 917.13.350); and by a grant from the leDucq Foundation (Cure Phospholamban Induced Cardiomyopathy). Dr Moslehi is supported by National Institutes of Health grants R56 141466 and R01 141466.

Topics & Concepts

MedicineCancerDiseaseInternal medicinePopulationEpidemiologyClinical OncologyGerontologyOncologyEnvironmental healthChemotherapy-induced cardiotoxicity and mitigationCardiac tumors and thrombiCardiac Imaging and Diagnostics
Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease | Litcius